BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
207.1603168
NSE Symbol
ALIVUS
Divident Yield %
2.07
Market Cap
(Rs In Cr.)
13,342
P/E (TTM)
30.2
EPS (TTM)
36.05
Face Value
(Rs)
2
Back
Alivus Life Sciences standalone net profit rises 15.32% in the December 2024 quarter
23-Jan-25   Hrs IST

Net profit of Alivus Life Sciences rose 15.32% to Rs 136.96 crore in the quarter ended December 2024 as against Rs 118.77 crore during the previous quarter ended December 2023. Sales rose 12.05% to Rs 641.84 crore in the quarter ended December 2024 as against Rs 572.80 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales641.84572.80 12
OPM %29.6530.13 -
PBDT200.31173.87 15
PBT185.15160.69 15
NP136.96118.77 15

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)